共 35 条
- [31] The Age of BLood Evaluation (ABLE) randomised controlled trial: description of the UK-funded arm of the international trial, the UK cost-utility analysis and secondary analyses exploring factors associated with health-related quality of life and health-care costs during the 12-month follow-up HEALTH TECHNOLOGY ASSESSMENT, 2017, 21 (62) : 1 - +
- [33] Cost-effectiveness of a non-pharmacological treatment vs. "care as usual" in day care centers for community-dwelling older people with cognitive impairment: results from the German randomized controlled DeTaMAKS-trial EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2020, 21 (06): : 825 - 844
- [34] Cost-effectiveness of a non-pharmacological treatment vs. “care as usual” in day care centers for community-dwelling older people with cognitive impairment: results from the German randomized controlled DeTaMAKS-trial The European Journal of Health Economics, 2020, 21 : 825 - 844